RESEARCH TRIANGLE PARK, NC, July 16, 2019 — Pappas Capital, a leading investor in early-stage life sciences companies, today announced the promotion of Kyle Rasbach, PhD, PharmD to a Managing...
Milestone Pharmaceuticals Appoints Paul Truex to the Board of Directors
News | 03. 05. 2012
Milestone Pharmaceuticals
Anthera Pharmaceuticals
MONTREAL, March 5, 2012 (GLOBE NEWSWIRE) Milestone Pharmaceuticals Inc., a cardiovascular drug development company, today announced the appointment of Paul F. Truex to its Board of Directors. Mr. Truex is Chief Executive Officer, Founder and a Director of Anthera Pharmaceuticals Inc. (Nasdaq:ANTH), a biopharmaceutical company focused on developing drugs to treat serious illnesses, including cardiovascular and autoimmune diseases.
